CB1 antagonist 4
CB1 antagonist 4 (compound 8) is a peripheral selective cannabinoid receptor type 1 (CB1) receptor antagonist. CB1 antagonist 4 shows limited penetrance to the brain in order to minimize or prevent CNS adverse reactions, and preserves potential antiobesity effects. CB1 antagonist 4 reduces propensity for psychiatric side effects[1][2].
Product Specifications
CAS Number
1253641-65-4
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/cb1-antagonist-4.html
Purity
98.00
Solubility
DMSO : 41.67 mg/mL (ultrasonic)
Smiles
O=C(C1=NN(C2=CC=C(Cl)C=C2Cl)C(C3=CC=C(C#CC4=CC=C(C(F)(F)F)C=C4)S3)=C1CC)NN5CCCCC5
Molecular Formula
C30H25Cl2F3N4OS
Molecular Weight
617.51
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CB1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 8/18 (C-51), CF647 conjugate, 0.1mg/mL
Recombinant Human Thioredoxin/TXN Protein (His Tag)
Recombinant Human Thioredoxin/TXN Protein (His Tag)
![Spiro[11H-dibenz[b,e]azepine-11,2'-[1,3]dioxolan]-6(5H)-one](https://cdn.genprice.uk/products/572/3665293370449/imageurl/trc-s679260-50mg.webp)
Spiro[11H-dibenz[b,e]azepine-11,2'-[1,3]dioxolan]-6(5H)-one
